logo

For the Inventor, By the Inventor

Loos, France

Genfit


USPTO Granted Patents = 72

% Expired Patents = 12.5



Trademarks = 20

Forward Citations = 263

Loading Chart...
Loading Chart...

55 inventors (with patents filed for the assignee):

goldMedal Robert Walczak (25 out of 25 patents)

silverMedal Rémy Hanf (23 out of 23 patents)

bronzeMedal Raphael Darteil (14 out of 14 patents)

4.  Karine Caumont-Bertrand (13 out of 13 patents)

5.  Carole Belanger (12 out of 12 patents)

6.  Dean Hum (10 out of 10 patents)

7.  Jean-Francois Delhomel (9 out of 9 patents)

8.  Peggy Parroche (8 out of 8 patents)

9.  Philippe Delataille (8 out of 8 patents)

10.  Ingrid Dufour (8 out of 8 patents)

11.  Zouher Majd (7 out of 7 patents)

12.  Benoît Noel (7 out of 7 patents)

13.  Enrico Perspicace (6 out of 6 patents)

14.  Corinne Foucart (6 out of 6 patents)

15.  Emilie Negro (6 out of 6 patents)


Core Competencies:
Cholestatic Diseases
Elafibranor
NASH Diagnosis
RORgamma Modulators
Combination Therapy
Fibrotic Diseases
1,3-Diphenylprop-2-en-1-one
Pharmaceutical Compositions
Non-Alcoholic Fatty Liver
Autoimmune Diseases
Histological Imaging
Patents

72 patents:

1. 12678427 - Combination therapy having antioxydant properties (2026-07-14),
2. 12673035 - Solid dosage forms of elafibranor (2026-07-07),
3. 12638460 - METHOD FOR NASH RISK ASSESSMENT (2026-05-26),
4. 12589086 - Compositions and methods for the treatment of primary biliary cholangitis (2026-03-31),
5. 12522564 - Polymorphs of elafibranor (2026-01-13),
6. 12458612 - Combination therapy comprising compounds of formula (I) and GLP-1 receptor agonists (2025-11-04),
7. 12391712 - Phosphate derivatives of RORgamma modulators and uses thereof (2025-08-19),
8. 12310935 - Methods of treatment of cholestatic diseases (2025-05-27),
9. 12303480 - Methods of treatment of cholestatic diseases (2025-05-20),
10. 12295928 - Methods of treatment of cholestatic diseases (2025-05-13),
11. 12295927 - Methods of treatment of cholestatic diseases (2025-05-13),
12. 12290498 - Methods of treatment of cholestatic diseases (2025-05-06),
13. 12233038 - Methods of treatment of cholestatic diseases (2025-02-25),
14. 12208087 - Combination of nitazoxanide and elafibranor for the treatment of immune diseases or inflammation (2025-01-28),
15. 12104209 - Non-invasive diagnostic of non-alcoholic steatohepatitis (2024-10-01),
Genfit is a biopharmaceutical company focused on discovering and developing innovative therapeutic and diagnostic solutions for metabolic and liver-related diseases. With a strong expertise in the field of liver diseases, Genfit is dedicated to improving the health of millions of patients worldwide through advanced research and development efforts.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Genfit
72 Patents

#1 in Loos

#358 in France

#10,370 in the World

Loos, FR
Loos, France

Genfit

Forward Citations = 263

55 inventors:

goldMedal Robert Walczak (25 out of 25 patents)

silverMedal Rémy Hanf (23 out of 23 patents)

bronzeMedal Raphael Darteil (14 out of 14 patents)

4.  Karine Caumont-Bertrand (13 out of 13 patents)

5.  Carole Belanger (12 out of 12 patents)

Please report any incorrect information to [email protected]
Loading…